Prof Friedemann Paul, head of the Experimental and Clinical Research Center (ECRC) at Charité – Universitätsmedizin Berlin and the Max Delbrück Center (MDC), is an established scientist in the field of neuroimmunology. Prof. Paul also leads the research group Clinical Neuroimmunology at the Neuroscience Clinical Research Center (NCRC). His research, with its translational approach, aims to directly translate findings into improvements in the diagnosis and treatment of neurological diseases. Prof. Paul is a partner of the collaborative research project VADYS-ME, which investigates the pathomechanisms of ME/CFS. This project utilises structural and functional magnetic resonance imaging (MRI) of the brain to explore potential vascular dysfunctions and hypoperfusion in ME/CFS patients.